p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?
Squamous cell carcinoma of the esophagus (SCCE) is diagnosed late and carries a poor prognosis. Lugol chromoendoscopy (LC) has being shown a useful tool in the management of patients at high risk for SCCE. Biomarkers such as p53 protein expression may be present in the esophageal mucosa long before...
Gespeichert in:
Veröffentlicht in: | Cancer detection and prevention 2005-01, Vol.29 (3), p.227-232 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 232 |
---|---|
container_issue | 3 |
container_start_page | 227 |
container_title | Cancer detection and prevention |
container_volume | 29 |
creator | Fagundes, Renato B. Melo, Carlos R. Pütten, Antonio C.K. Moreira, Luis F. de Barros, Sérgio G.S. |
description | Squamous cell carcinoma of the esophagus (SCCE) is diagnosed late and carries a poor prognosis. Lugol chromoendoscopy (LC) has being shown a useful tool in the management of patients at high risk for SCCE. Biomarkers such as p53 protein expression may be present in the esophageal mucosa long before esophageal symptoms or lesions appear and may aid in early diagnosis. This study was carried out to investigate the p53 immunoexpression in esophageal mucosa of smokers and alcohol consumers and study its relationship with different degrees of histological findings and the role of LC to detect areas that express p53.
Methods: Group 1: One hundred and eighty-two asymptomatic subjects at high risk for SCCE (consumption of more than 80
g of ethanol and 10 cigarettes/day for at least 10 years). Group 2: Twenty healthy volunteers who neither smoked nor consumed alcohol. Both groups underwent upper GI endoscopy plus LC, with biopsies of the esophageal mucosa. Expression of p53 protein was compared to histological findings.
Results: Group 1: There was 25/182 (14%) Lugol's unstained areas. p53 protein was expressed in a stepwise fashion according to the severity of the histological findings: normal mucosa (12/103 or 12%), mild esophagitis (6/43 or 14%), moderate esophagitis (4/18 or 22%), severe esophagitis (1/3 or 33%), low-grade dysplasia (4/11 or 36%), high-grade dysplasia (2/2 or 100%) and squamous cell carcinoma (2/2 or 100%) (
p
=
0.001). Nine in 25 (36%) patients with Lugol's unstained areas and 22/157 (14%) with normal appearing Lugol's stained mucosa expressed p53. Group 2: There was no Lugol unstained areas. The histological analysis and immunohistochemistry for p53 were normal with the exception of two patients that presented mild esophagitis and expressed p53. Unstained areas were 3.5 times (95% CI: 1.2–9.6) more likely to express p53 then stained ones. Alcoholics/smokers were 1.9 (95% CI: 0.4–8) times more likely to express p53 than non-alcoholics/non smokers.
Conclusions: In this study, we find an association between histological alterations, p53 expression and Lugol's unstained areas. It may point to a higher risk for SCCE. Smokers and alcohol drinkers with normal mucosa or chronic esophagitis that express p53 protein may represent an unrecognized sub-group of individuals that may benefit from surveillance or intervention. |
doi_str_mv | 10.1016/j.cdp.2005.01.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67897961</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0361090X05000255</els_id><sourcerecordid>3040230441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-4547d61bbd74b2d7561dcc095377309fc24e33c1f8678c35b4c0c05ecfe782273</originalsourceid><addsrcrecordid>eNp9kU2L1TAUhoMoznX0B7iRgOCuNWmaptXFMAx-wYAbhdmFNDm9zfU26eS0g_4Nf7Ep94LgwlXg8LwP4X0JeclZyRlv3h5K6-ayYkyWjJeMiUdkx1sliroWd4_JjomGF6xjdxfkGeKB5Uwnmqfkgsv8yo7vyO9ZCuqnaQ0Rfs4JEH0M7-h1oMY7ukRqY3iAsOSrOdIJljE6pD7QZQSKNgEEH_Y0DjSH7ZowJnqETYLbEe9XM8UVKWCcR7OHLLEmWEibYzaLz26kZqGj349F8vjj6jl5Mpgjwovze0m-f_zw7eZzcfv105eb69vCCtUtRS1r5Rre907VfeWUbLizlnVSKCVYN9iqBiEsH9pGtVbIvrbMMgl2ANVWlRKX5M3JO6d4vwIuevJo4Xg0AfKXdY51qmt4Bl__Ax7imnIfqHnN26bhTNaZ4ifKpoiYYNBz8pNJvzRneptLH3SeS29zacZ1nitnXp3Naz-B-5s475OB9ycAchEPHpJGmyuz4Hyue9Eu-v_o_wDSpKdN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1418661054</pqid></control><display><type>article</type><title>p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Fagundes, Renato B. ; Melo, Carlos R. ; Pütten, Antonio C.K. ; Moreira, Luis F. ; de Barros, Sérgio G.S.</creator><creatorcontrib>Fagundes, Renato B. ; Melo, Carlos R. ; Pütten, Antonio C.K. ; Moreira, Luis F. ; de Barros, Sérgio G.S.</creatorcontrib><description>Squamous cell carcinoma of the esophagus (SCCE) is diagnosed late and carries a poor prognosis. Lugol chromoendoscopy (LC) has being shown a useful tool in the management of patients at high risk for SCCE. Biomarkers such as p53 protein expression may be present in the esophageal mucosa long before esophageal symptoms or lesions appear and may aid in early diagnosis. This study was carried out to investigate the p53 immunoexpression in esophageal mucosa of smokers and alcohol consumers and study its relationship with different degrees of histological findings and the role of LC to detect areas that express p53.
Methods: Group 1: One hundred and eighty-two asymptomatic subjects at high risk for SCCE (consumption of more than 80
g of ethanol and 10 cigarettes/day for at least 10 years). Group 2: Twenty healthy volunteers who neither smoked nor consumed alcohol. Both groups underwent upper GI endoscopy plus LC, with biopsies of the esophageal mucosa. Expression of p53 protein was compared to histological findings.
Results: Group 1: There was 25/182 (14%) Lugol's unstained areas. p53 protein was expressed in a stepwise fashion according to the severity of the histological findings: normal mucosa (12/103 or 12%), mild esophagitis (6/43 or 14%), moderate esophagitis (4/18 or 22%), severe esophagitis (1/3 or 33%), low-grade dysplasia (4/11 or 36%), high-grade dysplasia (2/2 or 100%) and squamous cell carcinoma (2/2 or 100%) (
p
=
0.001). Nine in 25 (36%) patients with Lugol's unstained areas and 22/157 (14%) with normal appearing Lugol's stained mucosa expressed p53. Group 2: There was no Lugol unstained areas. The histological analysis and immunohistochemistry for p53 were normal with the exception of two patients that presented mild esophagitis and expressed p53. Unstained areas were 3.5 times (95% CI: 1.2–9.6) more likely to express p53 then stained ones. Alcoholics/smokers were 1.9 (95% CI: 0.4–8) times more likely to express p53 than non-alcoholics/non smokers.
Conclusions: In this study, we find an association between histological alterations, p53 expression and Lugol's unstained areas. It may point to a higher risk for SCCE. Smokers and alcohol drinkers with normal mucosa or chronic esophagitis that express p53 protein may represent an unrecognized sub-group of individuals that may benefit from surveillance or intervention.</description><identifier>ISSN: 0361-090X</identifier><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1873-443X</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.cdp.2005.01.003</identifier><identifier>PMID: 15936591</identifier><identifier>CODEN: CDPRD4</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Alcohol Drinking - adverse effects ; Biomarkers ; Biopsy ; Cancer ; Carcinoma, Squamous Cell - genetics ; Case-Control Studies ; Chromoendoscopy ; Coloring Agents ; Confidence intervals ; Epidemiology ; Esophageal cancer ; Esophageal Neoplasms - genetics ; Esophagitis - complications ; Esophagitis - genetics ; Gene Expression Profiling ; Genetic Predisposition to Disease ; Humans ; Immunohistochemistry ; Intestinal Mucosa - pathology ; Iodides ; Lugol ; Male ; Methods ; Middle Aged ; Mutation ; Prognosis ; Proteins ; Risk Factors ; Smoking - adverse effects ; Tobacco ; Tumor Suppressor Protein p53 - biosynthesis ; Tumor Suppressor Protein p53 - genetics</subject><ispartof>Cancer detection and prevention, 2005-01, Vol.29 (3), p.227-232</ispartof><rights>2005 International Society for Preventive Oncology</rights><rights>Copyright Elsevier Limited 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-4547d61bbd74b2d7561dcc095377309fc24e33c1f8678c35b4c0c05ecfe782273</citedby><cites>FETCH-LOGICAL-c379t-4547d61bbd74b2d7561dcc095377309fc24e33c1f8678c35b4c0c05ecfe782273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15936591$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fagundes, Renato B.</creatorcontrib><creatorcontrib>Melo, Carlos R.</creatorcontrib><creatorcontrib>Pütten, Antonio C.K.</creatorcontrib><creatorcontrib>Moreira, Luis F.</creatorcontrib><creatorcontrib>de Barros, Sérgio G.S.</creatorcontrib><title>p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?</title><title>Cancer detection and prevention</title><addtitle>Cancer Detect Prev</addtitle><description>Squamous cell carcinoma of the esophagus (SCCE) is diagnosed late and carries a poor prognosis. Lugol chromoendoscopy (LC) has being shown a useful tool in the management of patients at high risk for SCCE. Biomarkers such as p53 protein expression may be present in the esophageal mucosa long before esophageal symptoms or lesions appear and may aid in early diagnosis. This study was carried out to investigate the p53 immunoexpression in esophageal mucosa of smokers and alcohol consumers and study its relationship with different degrees of histological findings and the role of LC to detect areas that express p53.
Methods: Group 1: One hundred and eighty-two asymptomatic subjects at high risk for SCCE (consumption of more than 80
g of ethanol and 10 cigarettes/day for at least 10 years). Group 2: Twenty healthy volunteers who neither smoked nor consumed alcohol. Both groups underwent upper GI endoscopy plus LC, with biopsies of the esophageal mucosa. Expression of p53 protein was compared to histological findings.
Results: Group 1: There was 25/182 (14%) Lugol's unstained areas. p53 protein was expressed in a stepwise fashion according to the severity of the histological findings: normal mucosa (12/103 or 12%), mild esophagitis (6/43 or 14%), moderate esophagitis (4/18 or 22%), severe esophagitis (1/3 or 33%), low-grade dysplasia (4/11 or 36%), high-grade dysplasia (2/2 or 100%) and squamous cell carcinoma (2/2 or 100%) (
p
=
0.001). Nine in 25 (36%) patients with Lugol's unstained areas and 22/157 (14%) with normal appearing Lugol's stained mucosa expressed p53. Group 2: There was no Lugol unstained areas. The histological analysis and immunohistochemistry for p53 were normal with the exception of two patients that presented mild esophagitis and expressed p53. Unstained areas were 3.5 times (95% CI: 1.2–9.6) more likely to express p53 then stained ones. Alcoholics/smokers were 1.9 (95% CI: 0.4–8) times more likely to express p53 than non-alcoholics/non smokers.
Conclusions: In this study, we find an association between histological alterations, p53 expression and Lugol's unstained areas. It may point to a higher risk for SCCE. Smokers and alcohol drinkers with normal mucosa or chronic esophagitis that express p53 protein may represent an unrecognized sub-group of individuals that may benefit from surveillance or intervention.</description><subject>Adult</subject><subject>Alcohol Drinking - adverse effects</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Case-Control Studies</subject><subject>Chromoendoscopy</subject><subject>Coloring Agents</subject><subject>Confidence intervals</subject><subject>Epidemiology</subject><subject>Esophageal cancer</subject><subject>Esophageal Neoplasms - genetics</subject><subject>Esophagitis - complications</subject><subject>Esophagitis - genetics</subject><subject>Gene Expression Profiling</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Intestinal Mucosa - pathology</subject><subject>Iodides</subject><subject>Lugol</subject><subject>Male</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>Risk Factors</subject><subject>Smoking - adverse effects</subject><subject>Tobacco</subject><subject>Tumor Suppressor Protein p53 - biosynthesis</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><issn>0361-090X</issn><issn>1877-7821</issn><issn>1873-443X</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU2L1TAUhoMoznX0B7iRgOCuNWmaptXFMAx-wYAbhdmFNDm9zfU26eS0g_4Nf7Ep94LgwlXg8LwP4X0JeclZyRlv3h5K6-ayYkyWjJeMiUdkx1sliroWd4_JjomGF6xjdxfkGeKB5Uwnmqfkgsv8yo7vyO9ZCuqnaQ0Rfs4JEH0M7-h1oMY7ukRqY3iAsOSrOdIJljE6pD7QZQSKNgEEH_Y0DjSH7ZowJnqETYLbEe9XM8UVKWCcR7OHLLEmWEibYzaLz26kZqGj349F8vjj6jl5Mpgjwovze0m-f_zw7eZzcfv105eb69vCCtUtRS1r5Rre907VfeWUbLizlnVSKCVYN9iqBiEsH9pGtVbIvrbMMgl2ANVWlRKX5M3JO6d4vwIuevJo4Xg0AfKXdY51qmt4Bl__Ax7imnIfqHnN26bhTNaZ4ifKpoiYYNBz8pNJvzRneptLH3SeS29zacZ1nitnXp3Naz-B-5s475OB9ycAchEPHpJGmyuz4Hyue9Eu-v_o_wDSpKdN</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Fagundes, Renato B.</creator><creator>Melo, Carlos R.</creator><creator>Pütten, Antonio C.K.</creator><creator>Moreira, Luis F.</creator><creator>de Barros, Sérgio G.S.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050101</creationdate><title>p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?</title><author>Fagundes, Renato B. ; Melo, Carlos R. ; Pütten, Antonio C.K. ; Moreira, Luis F. ; de Barros, Sérgio G.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-4547d61bbd74b2d7561dcc095377309fc24e33c1f8678c35b4c0c05ecfe782273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Alcohol Drinking - adverse effects</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Case-Control Studies</topic><topic>Chromoendoscopy</topic><topic>Coloring Agents</topic><topic>Confidence intervals</topic><topic>Epidemiology</topic><topic>Esophageal cancer</topic><topic>Esophageal Neoplasms - genetics</topic><topic>Esophagitis - complications</topic><topic>Esophagitis - genetics</topic><topic>Gene Expression Profiling</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Intestinal Mucosa - pathology</topic><topic>Iodides</topic><topic>Lugol</topic><topic>Male</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>Risk Factors</topic><topic>Smoking - adverse effects</topic><topic>Tobacco</topic><topic>Tumor Suppressor Protein p53 - biosynthesis</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fagundes, Renato B.</creatorcontrib><creatorcontrib>Melo, Carlos R.</creatorcontrib><creatorcontrib>Pütten, Antonio C.K.</creatorcontrib><creatorcontrib>Moreira, Luis F.</creatorcontrib><creatorcontrib>de Barros, Sérgio G.S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer detection and prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fagundes, Renato B.</au><au>Melo, Carlos R.</au><au>Pütten, Antonio C.K.</au><au>Moreira, Luis F.</au><au>de Barros, Sérgio G.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?</atitle><jtitle>Cancer detection and prevention</jtitle><addtitle>Cancer Detect Prev</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>29</volume><issue>3</issue><spage>227</spage><epage>232</epage><pages>227-232</pages><issn>0361-090X</issn><issn>1877-7821</issn><eissn>1873-443X</eissn><eissn>1877-783X</eissn><coden>CDPRD4</coden><abstract>Squamous cell carcinoma of the esophagus (SCCE) is diagnosed late and carries a poor prognosis. Lugol chromoendoscopy (LC) has being shown a useful tool in the management of patients at high risk for SCCE. Biomarkers such as p53 protein expression may be present in the esophageal mucosa long before esophageal symptoms or lesions appear and may aid in early diagnosis. This study was carried out to investigate the p53 immunoexpression in esophageal mucosa of smokers and alcohol consumers and study its relationship with different degrees of histological findings and the role of LC to detect areas that express p53.
Methods: Group 1: One hundred and eighty-two asymptomatic subjects at high risk for SCCE (consumption of more than 80
g of ethanol and 10 cigarettes/day for at least 10 years). Group 2: Twenty healthy volunteers who neither smoked nor consumed alcohol. Both groups underwent upper GI endoscopy plus LC, with biopsies of the esophageal mucosa. Expression of p53 protein was compared to histological findings.
Results: Group 1: There was 25/182 (14%) Lugol's unstained areas. p53 protein was expressed in a stepwise fashion according to the severity of the histological findings: normal mucosa (12/103 or 12%), mild esophagitis (6/43 or 14%), moderate esophagitis (4/18 or 22%), severe esophagitis (1/3 or 33%), low-grade dysplasia (4/11 or 36%), high-grade dysplasia (2/2 or 100%) and squamous cell carcinoma (2/2 or 100%) (
p
=
0.001). Nine in 25 (36%) patients with Lugol's unstained areas and 22/157 (14%) with normal appearing Lugol's stained mucosa expressed p53. Group 2: There was no Lugol unstained areas. The histological analysis and immunohistochemistry for p53 were normal with the exception of two patients that presented mild esophagitis and expressed p53. Unstained areas were 3.5 times (95% CI: 1.2–9.6) more likely to express p53 then stained ones. Alcoholics/smokers were 1.9 (95% CI: 0.4–8) times more likely to express p53 than non-alcoholics/non smokers.
Conclusions: In this study, we find an association between histological alterations, p53 expression and Lugol's unstained areas. It may point to a higher risk for SCCE. Smokers and alcohol drinkers with normal mucosa or chronic esophagitis that express p53 protein may represent an unrecognized sub-group of individuals that may benefit from surveillance or intervention.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15936591</pmid><doi>10.1016/j.cdp.2005.01.003</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0361-090X |
ispartof | Cancer detection and prevention, 2005-01, Vol.29 (3), p.227-232 |
issn | 0361-090X 1877-7821 1873-443X 1877-783X |
language | eng |
recordid | cdi_proquest_miscellaneous_67897961 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Alcohol Drinking - adverse effects Biomarkers Biopsy Cancer Carcinoma, Squamous Cell - genetics Case-Control Studies Chromoendoscopy Coloring Agents Confidence intervals Epidemiology Esophageal cancer Esophageal Neoplasms - genetics Esophagitis - complications Esophagitis - genetics Gene Expression Profiling Genetic Predisposition to Disease Humans Immunohistochemistry Intestinal Mucosa - pathology Iodides Lugol Male Methods Middle Aged Mutation Prognosis Proteins Risk Factors Smoking - adverse effects Tobacco Tumor Suppressor Protein p53 - biosynthesis Tumor Suppressor Protein p53 - genetics |
title | p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A56%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=p53%20immunoexpression:%20An%20aid%20to%20conventional%20methods%20in%20the%20screening%20of%20precursor%20lesions%20of%20squamous%20esophageal%20cancer%20in%20patients%20at%20high-risk?&rft.jtitle=Cancer%20detection%20and%20prevention&rft.au=Fagundes,%20Renato%20B.&rft.date=2005-01-01&rft.volume=29&rft.issue=3&rft.spage=227&rft.epage=232&rft.pages=227-232&rft.issn=0361-090X&rft.eissn=1873-443X&rft.coden=CDPRD4&rft_id=info:doi/10.1016/j.cdp.2005.01.003&rft_dat=%3Cproquest_cross%3E3040230441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1418661054&rft_id=info:pmid/15936591&rft_els_id=S0361090X05000255&rfr_iscdi=true |